Search results

Set up email alerts

Opportunities found

Displaying items 376 - 400 of 487 in total

• Germany - The subject of this publication is the conclusion of non-exclusive discount agreements. Provided by Published: 09 June 2024 , Closing date: 30 April 2026
• Germany - The subject of this publication is the conclusion of non-exclusive discount agreements. Provided by Published: 19 May 2024 , Closing date: 30 April 2026
• Germany - The subject of this publication is the conclusion of contracts in accordance with Section 130a A Provided by Published: 12 May 2024 , Closing date: 04 May 2026
• Germany - The purpose of this notice is to conclude agreements with pharma Provided by Published: 06 August 2024 , Closing date: 05 May 2026
• Germany - Open framework agreement on drug discounts in accordance with Section 130a (8) sentence 1 SGB V with the option to join at any time, so-called approval model 2024-05 Provided by Published: 05 June 2024 , Closing date: 05 May 2026
• Germany - The purpose of this notice is to conclude agreements with pharma Provided by Published: 07 May 2024 , Closing date: 05 May 2026
• Germany - § Section 130a (8) SGB V enables the health insurance funds (KK) and pharmaceutical companies Provided by Published: 31 July 2024 , Closing date: 10 May 2026
• Germany - § Section 130a (8) SGB V enables the health insurance funds (KK) and pharmaceutical companies Provided by Published: 01 October 2024 , Closing date: 10 May 2026
• Germany - § Section 130a (8) SGB V enables the health insurance funds (KK) and pharmaceutical companies Provided by Published: 01 October 2024 , Closing date: 10 May 2026
• Germany - § Section 130a (8) SGB V enables the health insurance funds (KK) and pharmaceutical companies Provided by Published: 27 November 2024 , Closing date: 10 May 2026
• Germany - § Section 130a (8) SGB V enables the health insurance funds (KK) and pharmaceutical companies Provided by Published: 04 November 2024 , Closing date: 10 May 2026
• Germany - § Section 130a (8) SGB V enables the health insurance funds (KK) and pharmaceutical companies Provided by Published: 04 November 2024 , Closing date: 10 May 2026
• Germany - § Section 130a (8) SGB V enables the health insurance funds (KK) and pharmaceutical companies Provided by Published: 31 July 2024 , Closing date: 10 May 2026
• Germany - § Section 130a (8) SGB V enables the health insurance funds (KK) and pharmaceutical companies Provided by Published: 04 November 2024 , Closing date: 10 May 2026
• Germany - § Section 130a (8) SGB V enables the health insurance funds (KK) and pharmaceutical companies Provided by Published: 01 October 2024 , Closing date: 10 May 2026
• Germany - The purpose of this notice is to conclude agreements with pharma Provided by Published: 06 August 2024 , Closing date: 05 June 2026
• Germany - The participating health insurance funds pursue the goal of working with all suitable pharmaceutical Provided by Published: 12 May 2024 , Closing date: 30 June 2026
• Germany - The subject of this publication is the conclusion of non-exclusive discount agreements. Provided by Published: 09 June 2024 , Closing date: 30 June 2026
• Germany - The subject of this publication is the conclusion of non-exclusive discount agreements. Provided by Published: 05 July 2024 , Closing date: 30 June 2026
• Germany - The participating health insurance funds pursue the goal of working with all suitable pharmaceutical Provided by Published: 12 May 2024 , Closing date: 30 June 2026
• Germany - The subject of this publication is the conclusion of non-exclusive discount agreements. Provided by Published: 05 July 2024 , Closing date: 30 June 2026
• Germany - The subject of this publication is the conclusion of non-exclusive discount agreements. Provided by Published: 05 July 2024 , Closing date: 30 June 2026
• Germany - TK pursues the goal of working with all suitable pharmaceutical companies Rab Provided by Published: 19 May 2024 , Closing date: 30 June 2026
• Germany - Open framework agreement on drug discounts in accordance with Section 130a (8) sentence 1 SGB V with the option to join at any time, so-called approval model 2024-07 Provided by Published: 05 July 2024 , Closing date: 05 July 2026
• Germany - The purpose of this notice is to conclude agreements with pharma Provided by Published: 06 August 2024 , Closing date: 05 July 2026